We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

162 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 4

300% more funds holding in top 10

Funds holding in top 10: 2 → 8 (+6)

151% more capital invested

Capital invested by funds: $489M → $1.23B (+$737M)

56% more funds holding

Funds holding: 104 → 162 (+58)

40% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 35

29% more call options, than puts

Call options by funds: $34.6M | Put options by funds: $26.8M

Holders
162
Holders Change
+58
Holders Change %
+55.77%
% of All Funds
4.32%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
62
Increased
49
Reduced
35
Closed
4
Calls
$34.6M
Puts
$26.8M
Net Calls
+$7.76M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17.6M
2
FCMI
Foresite Capital Management II
California
+$15.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$12.3M
4
ACA
Avoro Capital Advisors
New York
+$11M
5
Ameriprise
Ameriprise
Minnesota
+$9.67M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.91M
3
PHS
PFM Health Sciences
California
-$8.27M
4
NC
Northpointe Capital
Michigan
-$4.54M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$4.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
51
Atika Capital Management
New York
$3.77M +$2.21M +100,000 New
Stifel Financial
52
Stifel Financial
Missouri
$3.59M -$395K -17,931 -16%
BIM
53
BlackRock Investment Management
Delaware
$3.53M -$4.61K -209 -0.2%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$3.49M -$155K -7,009 -7%
SAM
55
Senzar Asset Management
New York
$3.48M +$2.03M +92,200 New
DCM
56
DAFNA Capital Management
California
$3.47M -$1.52M -69,000 -43%
TAM
57
Tocqueville Asset Management
New York
$3.28M +$984K +44,600 +105%
BI
58
Boulegeris Investments
Georgia
$3.23M -$139K -6,325 -7%
B
59
Bailard
California
$3.13M -$662K -30,000 -27%
PIM
60
Platinum Investment Management
Australia
$2.98M -$948K -43,000 -35%
HCM
61
Harvey Capital Management
Florida
$2.79M -$773K -35,075 -32%
PCM
62
Prelude Capital Management
New York
$2.46M +$1.44M +65,228 New
BCA
63
Benchmark Capital Advisors
New York
$2.38M +$187K +8,500 +16%
Bank of America
64
Bank of America
North Carolina
$2.34M -$35.8K -1,622 -3%
PPA
65
Parametric Portfolio Associates
Washington
$2.33M +$324K +14,677 +31%
Morgan Stanley
66
Morgan Stanley
New York
$2.31M +$385K +17,470 +40%
NFA
67
Nationwide Fund Advisors
Ohio
$2.31M -$404K -18,320 -23%
EA
68
Emerald Acquisition
Washington
$1.96M +$1.15M +51,976 New
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$1.93M +$11K +500 +1%
American Century Companies
70
American Century Companies
Missouri
$1.9M +$1.11M +50,206 New
NC
71
Nexthera Capital
New York
$1.89M -$1.33M -60,280 -55%
WMSA
72
Weiss Multi-Strategy Advisers
New York
$1.89M +$1.1M +50,000 New
Jane Street
73
Jane Street
New York
$1.81M +$1.06M +48,018 New
SPPAM
74
Summit Partners Public Asset Management
Massachusetts
$1.7M +$992K +45,000 New
Swiss National Bank
75
Swiss National Bank
Switzerland
$1.63M +$110K +5,000 +13%
1 2
3
4 5

AERI Hedge Fund Activity: Q3 2016 in Review

162 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2016, worth a combined $1.23B — up 151% from $489M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new AERI positions and 4 closed out — a net gain of 58 holders — while 49 added to existing stakes and 35 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $17.6M. The largest seller was Deerfield Management, cutting an estimated $26.1M.

  • 162 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $1.23B of Aerie Pharmaceuticals stock for Q3 2016, up 151% quarter-over-quarter.
  • 62 funds opened new Aerie Pharmaceuticals positions in Q3 2016 and 4 closed out, a net change of +58 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2016 was OrbiMed, an estimated $17.6M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2016 was Deerfield Management, an estimated $26.1M sold.

Based on aggregated 13F filings for Q3 2016.